MARKET

ICCC

ICCC

ImmuCell
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.220
-0.060
-1.40%
Closed 16:00 05/27 EDT
OPEN
4.350
PREV CLOSE
4.280
HIGH
4.350
LOW
4.115
VOLUME
36.13K
TURNOVER
--
52 WEEK HIGH
8.13
52 WEEK LOW
3.700
MARKET CAP
30.44M
P/E (TTM)
-19.4739
1D
5D
1M
3M
1Y
5Y

ICCC News

More
Edited Transcript of ICCC earnings conference call or presentation 14-May-20 1:00pm GMT
Q1 2020 ImmuCell Corp Earnings Call
Thomson Reuters StreetEvents · 05/18 15:48
ImmuCell Corporation (ICCC) CEO Michael Brigham on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/14 19:14
ImmuCell Corporation to Present at Lytham Partners Virtual Investor Conference
ImmuCell Corporation (NASDAQ: ICCC) a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced it will participate in a
PR Newswire · 05/14 17:35
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
GlobeNewswire · 05/14 13:42
ImmuCell reports Q1 results
ImmuCell (NASDAQ:ICCC): Q1 GAAP EPS of -$0.02. Revenue of $4.91M (+11.3% Y/Y) Press Release
seekingalpha · 05/14 01:10
ImmuCell Q1 EPS $(0.020) Down From $0.030 YoY, Sales $4.910M Up From $4.411M YoY
ImmuCell (NASDAQ:ICCC) reported quarterly losses of $(0.020) per share. This is a 166.67 percent decrease over earnings of $0.030 per share from the same period last year. The company reported $4.910 million in sales
Benzinga · 05/13 20:10
ImmuCell Announces Unaudited Financial Results for the First Quarter Ended March 31, 2020
PORTLAND, Maine, May 13, 2020 -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets.
GlobeNewswire · 05/13 20:05
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40

Industry

Biotechnology & Medical Research
+0.53%
Pharmaceuticals & Medical Research
+0.23%

Hot Stocks

Symbol
Price
%Change

About ICCC

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.
More

Webull offers kinds of ImmuCell Corporation stock information, including NASDAQ:ICCC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICCC stock news, and many more online research tools to help you make informed decisions.